Following a recent announcement by drug manufacturer Merck, Sanofi recently sent letters to 340B covered entities with contract pharmacy arrangements to request that they participate
Merck Requests That Covered Entities Submit Contract Pharmacy Claims to 340B ESP
Drug manufacturer Merck recently sent letters to 340B covered entities with contract pharmacy arrangements
The US Conference on HIV/AIDS (USCHA) announced that this year’s conference will be held virtually on October 19-21, 2020. Registration is free for the first
Federally funded clinics that serve over half a million people living with HIV/AIDS have asked the Trump administration to waive regulations preventing them from using
Powers drafted the attached template COVID-19 Policies and Procedures that incorporate HRSA/OPA’s relaxed guidance to help 340B covered entities address the coronavirus pandemic. We hope
HRSA/OPA Guidance in Response to COVID-19
Late yesterday, HRSA/OPA updated its website to include guidance addressing the COVID-19 pandemic. The guidance states:
Case-by-Case Waivers –
The COVID-19 pandemic has created an increased need for the use of telehealth services. Powers has received several questions from Ryan White clinics about whether
On February 10, 2020, the White House released the
Administration’s budget proposal for Fiscal Year (FY) 2021, A
Budget For America’s Future. This document summarizes the President’s
recommendations
On January 28, 2020, HRSA posted results
of its 340B Program audit of four pharmaceutical manufacturers in fiscal year 2019. Three of the four
audited manufacturers were
On January
27, 2020, the U.S. Government Accountability Office (GAO) released a report (the Report) assessing oversight
by the Department of Health and Human Services (HHS) of
